S M L Aversa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Sir, We read with great interest the article by Arnould et al (2006). In their study, they investigated by immunohistochemistry (IHC) immune cell response during neoadjuvant primary systemic therapy with trastuzumab and docetaxel in patients with IHC 3 þ HER2-positive primary breast cancer. Trastuzumab treatment was associated with significantly increased(More)
  • 1